Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis [version 1; referees: 1 approved, 2 approved with reservations]

Prostate specific antigen (PSA) kinetic as a prognostic factor in metastatic prostate cancer receiving androgen deprivation therapy: systematic review and meta-analysis [version 1; referees: 1 approved, 2 approved with reservations]

Aim: Metastatic prostate cancer (mPCa) has a poor outcome with median survival of two to five years. The use of androgen deprivation therapy (ADT) is a gold standard in management of this stage.  Aim of this study is to analyze the prognostic value of PSA kinetics of patient treated with hormonal th...

Full description

Bibliographic Details
Main Authors: Andika Afriansyah, Agus Rizal Ardy Hariandy Hamid, Chaidir Arif Mochtar, Rainy Umbas
Format: Article
Language:English
Published: F1000 Research Ltd 2018-02-01
Series:F1000Research
Online Access:https://f1000research.com/articles/7-246/v1

Similar Items

Similar Items